Chinese medical device makers push into Europe as anti-corruption squeeze bites at home
Facing anti-corruption policies and profit squeezing at home, Chinese innovative medical device companies are accelerating their push into the European market despite mounting cross-border trade…
Read the full articleYou might also wanna read
China Compliance Update: Life Sciences — Spring 2026
In 2026, Chinese regulators have continued their focus on anti-corruption enforcement in the life sciences industry. In addition to long-sta
China Finalizes Regulations for Pharmaceutical Sales Representatives
China’s 2026 Management Measures for Medical Representatives significantly expand pharmaceutical compliance obligations by imposing stricter
China’s drug industry pivots to AI-powered candidates to drive next wave of deals
After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towa
China’s drug industry pivots to AI-powered candidates to drive next wave of deals
After China’s cross-border deals for innovative drugs hit a record US$110 billion in the first half of 2026, the sector is now pivoting towa
Medical Device Industry Payments to Healthcare Professionals and Organizations in Japan: An Evaluation of Scale, Distribution, and Transparency Practices, 2019-2022
Background Financial relationships between the medical device industry and healthcare providers have raised concerns about conflicts of inte
China Compliance Update: Anti-Corruption — Spring 2026
Anti-corruption continued to be a major focus for Chinese regulators in 2026, with the Supreme People’s Court publishing its first new judic
Comments
Sign in to join the conversation.
No comments yet. Be the first.